Click for best price
Bipolar Disorder Medications Market Size, Share 2024
The global Bipolar Disorder Medications market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Mood Stabilizers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Bipolar Disorder Medications include AbbVie Inc., Glaxo SmithKline (GSK), Eli Lily and Company, Janssen Pharmaceuticals, Johnson & Johnson, Astellas Pharma Inc, Bristol Myers Squibb, Gedeon Richter PLC. and H. Lundbeck A/S, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Drug therapy is currently the core method of treating bipolar disorder, that is, the use of emotional stabilizers to adjust the patient's mood. Bipolar disorder is complex and difficult to control. The drug effect of emotional stabilizers can help patients to suppress their emotions when they are too high, to increase their emotions when they are depressed, to stabilize their emotions at a normal level, and to effectively prevent the recurrence of bipolar disorder. The quickest and most effective approach may be convulsive-free electroconvulsive therapy.
This report aims to provide a comprehensive presentation of the global market for Bipolar Disorder Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorder Medications. This report contains market size and forecasts of Bipolar Disorder Medications in global, including the following market information:
Global Bipolar Disorder Medications Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Bipolar Disorder Medications Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Bipolar Disorder Medications companies in 2023 (%)
We surveyed the Bipolar Disorder Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bipolar Disorder Medications Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Bipolar Disorder Medications Market Segment Percentages, by Type, 2023 (%)
Mood Stabilizers
Anticonvulsants
Antipsychotic Drugs
Antidepressant Drugs
Anti-Anxiety Drugs
Global Bipolar Disorder Medications Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Bipolar Disorder Medications Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Global Bipolar Disorder Medications Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Bipolar Disorder Medications Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bipolar Disorder Medications revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Bipolar Disorder Medications revenues share in global market, 2023 (%)
Key companies Bipolar Disorder Medications sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Bipolar Disorder Medications sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc.
Glaxo SmithKline (GSK)
Eli Lily and Company
Janssen Pharmaceuticals
Johnson & Johnson
Astellas Pharma Inc
Bristol Myers Squibb
Gedeon Richter PLC.
H. Lundbeck A/S
Pfizer Inc.
Novartis AG
Otsuka Holdings Co. Ltd
Validus Pharmaceuticals LLC.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bipolar Disorder Medications, market overview.
Chapter 2: Global Bipolar Disorder Medications market size in revenue and volume.
Chapter 3: Detailed analysis of Bipolar Disorder Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bipolar Disorder Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bipolar Disorder Medications capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Bipolar Disorder Medications Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
70 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Bipolar Disorder Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bipolar Disorder Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bipolar Disorder Medications Overall Market Size
2.1 Global Bipolar Disorder Medications Market Size: 2023 VS 2030
2.2 Global Bipolar Disorder Medications Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Bipolar Disorder Medications Sales: 2019-2030
3 Company Landscape
3.1 Top Bipolar Disorder Medications Players in Global Market
3.2 Top Global Bipolar Disorder Medications Companies Ranked by Revenue
3.3 Global Bipolar Disorder Medications Revenue by Companies
3.4 Global Bipolar Disorder Medications Sales by Companies
3.5 Global Bipolar Disorder Medications Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Bipolar Disorder Medications Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Bipolar Disorder Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bipolar Disorder Medications Players in Global Market
3.8.1 List of Global Tier 1 Bipolar Disorder Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Bipolar Disorder Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Bipolar Disorder Medications Market Size Markets, 2023 & 2030
4.1.2 Mood Stabilizers
4.1.3 Anticonvulsants
4.1.4 Antipsychotic Drugs
4.1.5 Antidepressant Drugs
4.1.6 Anti-Anxiety Drugs
4.2 By Type - Global Bipolar Disorder Medications Revenue & Forecasts
4.2.1 By Type - Global Bipolar Disorder Medications Revenue, 2019-2024
4.2.2 By Type - Global Bipolar Disorder Medications Revenue, 2025-2030
4.2.3 By Type - Global Bipolar Disorder Medications Revenue Market Share, 2019-2030
4.3 By Type - Global Bipolar Disorder Medications Sales & Forecasts
4.3.1 By Type - Global Bipolar Disorder Medications Sales, 2019-2024
4.3.2 By Type - Global Bipolar Disorder Medications Sales, 2025-2030
4.3.3 By Type - Global Bipolar Disorder Medications Sales Market Share, 2019-2030
4.4 By Type - Global Bipolar Disorder Medications Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bipolar Disorder Medications Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Bipolar Disorder Medications Revenue & Forecasts
5.2.1 By Application - Global Bipolar Disorder Medications Revenue, 2019-2024
5.2.2 By Application - Global Bipolar Disorder Medications Revenue, 2025-2030
5.2.3 By Application - Global Bipolar Disorder Medications Revenue Market Share, 2019-2030
5.3 By Application - Global Bipolar Disorder Medications Sales & Forecasts
5.3.1 By Application - Global Bipolar Disorder Medications Sales, 2019-2024
5.3.2 By Application - Global Bipolar Disorder Medications Sales, 2025-2030
5.3.3 By Application - Global Bipolar Disorder Medications Sales Market Share, 2019-2030
5.4 By Application - Global Bipolar Disorder Medications Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Bipolar Disorder Medications Market Size, 2023 & 2030
6.2 By Region - Global Bipolar Disorder Medications Revenue & Forecasts
6.2.1 By Region - Global Bipolar Disorder Medications Revenue, 2019-2024
6.2.2 By Region - Global Bipolar Disorder Medications Revenue, 2025-2030
6.2.3 By Region - Global Bipolar Disorder Medications Revenue Market Share, 2019-2030
6.3 By Region - Global Bipolar Disorder Medications Sales & Forecasts
6.3.1 By Region - Global Bipolar Disorder Medications Sales, 2019-2024
6.3.2 By Region - Global Bipolar Disorder Medications Sales, 2025-2030
6.3.3 By Region - Global Bipolar Disorder Medications Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Bipolar Disorder Medications Revenue, 2019-2030
6.4.2 By Country - North America Bipolar Disorder Medications Sales, 2019-2030
6.4.3 US Bipolar Disorder Medications Market Size, 2019-2030
6.4.4 Canada Bipolar Disorder Medications Market Size, 2019-2030
6.4.5 Mexico Bipolar Disorder Medications Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Bipolar Disorder Medications Revenue, 2019-2030
6.5.2 By Country - Europe Bipolar Disorder Medications Sales, 2019-2030
6.5.3 Germany Bipolar Disorder Medications Market Size, 2019-2030
6.5.4 France Bipolar Disorder Medications Market Size, 2019-2030
6.5.5 U.K. Bipolar Disorder Medications Market Size, 2019-2030
6.5.6 Italy Bipolar Disorder Medications Market Size, 2019-2030
6.5.7 Russia Bipolar Disorder Medications Market Size, 2019-2030
6.5.8 Nordic Countries Bipolar Disorder Medications Market Size, 2019-2030
6.5.9 Benelux Bipolar Disorder Medications Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Bipolar Disorder Medications Revenue, 2019-2030
6.6.2 By Region - Asia Bipolar Disorder Medications Sales, 2019-2030
6.6.3 China Bipolar Disorder Medications Market Size, 2019-2030
6.6.4 Japan Bipolar Disorder Medications Market Size, 2019-2030
6.6.5 South Korea Bipolar Disorder Medications Market Size, 2019-2030
6.6.6 Southeast Asia Bipolar Disorder Medications Market Size, 2019-2030
6.6.7 India Bipolar Disorder Medications Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Bipolar Disorder Medications Revenue, 2019-2030
6.7.2 By Country - South America Bipolar Disorder Medications Sales, 2019-2030
6.7.3 Brazil Bipolar Disorder Medications Market Size, 2019-2030
6.7.4 Argentina Bipolar Disorder Medications Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bipolar Disorder Medications Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Bipolar Disorder Medications Sales, 2019-2030
6.8.3 Turkey Bipolar Disorder Medications Market Size, 2019-2030
6.8.4 Israel Bipolar Disorder Medications Market Size, 2019-2030
6.8.5 Saudi Arabia Bipolar Disorder Medications Market Size, 2019-2030
6.8.6 UAE Bipolar Disorder Medications Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Company Summary
7.1.2 AbbVie Inc. Business Overview
7.1.3 AbbVie Inc. Bipolar Disorder Medications Major Product Offerings
7.1.4 AbbVie Inc. Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.1.5 AbbVie Inc. Key News & Latest Developments
7.2 Glaxo SmithKline (GSK)
7.2.1 Glaxo SmithKline (GSK) Company Summary
7.2.2 Glaxo SmithKline (GSK) Business Overview
7.2.3 Glaxo SmithKline (GSK) Bipolar Disorder Medications Major Product Offerings
7.2.4 Glaxo SmithKline (GSK) Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.2.5 Glaxo SmithKline (GSK) Key News & Latest Developments
7.3 Eli Lily and Company
7.3.1 Eli Lily and Company Company Summary
7.3.2 Eli Lily and Company Business Overview
7.3.3 Eli Lily and Company Bipolar Disorder Medications Major Product Offerings
7.3.4 Eli Lily and Company Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.3.5 Eli Lily and Company Key News & Latest Developments
7.4 Janssen Pharmaceuticals
7.4.1 Janssen Pharmaceuticals Company Summary
7.4.2 Janssen Pharmaceuticals Business Overview
7.4.3 Janssen Pharmaceuticals Bipolar Disorder Medications Major Product Offerings
7.4.4 Janssen Pharmaceuticals Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.4.5 Janssen Pharmaceuticals Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Bipolar Disorder Medications Major Product Offerings
7.5.4 Johnson & Johnson Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Astellas Pharma Inc
7.6.1 Astellas Pharma Inc Company Summary
7.6.2 Astellas Pharma Inc Business Overview
7.6.3 Astellas Pharma Inc Bipolar Disorder Medications Major Product Offerings
7.6.4 Astellas Pharma Inc Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.6.5 Astellas Pharma Inc Key News & Latest Developments
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Company Summary
7.7.2 Bristol Myers Squibb Business Overview
7.7.3 Bristol Myers Squibb Bipolar Disorder Medications Major Product Offerings
7.7.4 Bristol Myers Squibb Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.7.5 Bristol Myers Squibb Key News & Latest Developments
7.8 Gedeon Richter PLC.
7.8.1 Gedeon Richter PLC. Company Summary
7.8.2 Gedeon Richter PLC. Business Overview
7.8.3 Gedeon Richter PLC. Bipolar Disorder Medications Major Product Offerings
7.8.4 Gedeon Richter PLC. Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.8.5 Gedeon Richter PLC. Key News & Latest Developments
7.9 H. Lundbeck A/S
7.9.1 H. Lundbeck A/S Company Summary
7.9.2 H. Lundbeck A/S Business Overview
7.9.3 H. Lundbeck A/S Bipolar Disorder Medications Major Product Offerings
7.9.4 H. Lundbeck A/S Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.9.5 H. Lundbeck A/S Key News & Latest Developments
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Company Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Bipolar Disorder Medications Major Product Offerings
7.10.4 Pfizer Inc. Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.10.5 Pfizer Inc. Key News & Latest Developments
7.11 Novartis AG
7.11.1 Novartis AG Company Summary
7.11.2 Novartis AG Bipolar Disorder Medications Business Overview
7.11.3 Novartis AG Bipolar Disorder Medications Major Product Offerings
7.11.4 Novartis AG Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.11.5 Novartis AG Key News & Latest Developments
7.12 Otsuka Holdings Co. Ltd
7.12.1 Otsuka Holdings Co. Ltd Company Summary
7.12.2 Otsuka Holdings Co. Ltd Bipolar Disorder Medications Business Overview
7.12.3 Otsuka Holdings Co. Ltd Bipolar Disorder Medications Major Product Offerings
7.12.4 Otsuka Holdings Co. Ltd Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.12.5 Otsuka Holdings Co. Ltd Key News & Latest Developments
7.13 Validus Pharmaceuticals LLC.
7.13.1 Validus Pharmaceuticals LLC. Company Summary
7.13.2 Validus Pharmaceuticals LLC. Bipolar Disorder Medications Business Overview
7.13.3 Validus Pharmaceuticals LLC. Bipolar Disorder Medications Major Product Offerings
7.13.4 Validus Pharmaceuticals LLC. Bipolar Disorder Medications Sales and Revenue in Global (2019-2024)
7.13.5 Validus Pharmaceuticals LLC. Key News & Latest Developments
8 Global Bipolar Disorder Medications Production Capacity, Analysis
8.1 Global Bipolar Disorder Medications Production Capacity, 2019-2030
8.2 Bipolar Disorder Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Bipolar Disorder Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bipolar Disorder Medications Supply Chain Analysis
10.1 Bipolar Disorder Medications Industry Value Chain
10.2 Bipolar Disorder Medications Upstream Market
10.3 Bipolar Disorder Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bipolar Disorder Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Bipolar Disorder Medications in Global Market
Table 2. Top Bipolar Disorder Medications Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Bipolar Disorder Medications Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Bipolar Disorder Medications Revenue Share by Companies, 2019-2024
Table 5. Global Bipolar Disorder Medications Sales by Companies, (K Units), 2019-2024
Table 6. Global Bipolar Disorder Medications Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Bipolar Disorder Medications Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Bipolar Disorder Medications Product Type
Table 9. List of Global Tier 1 Bipolar Disorder Medications Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bipolar Disorder Medications Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Bipolar Disorder Medications Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Bipolar Disorder Medications Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Bipolar Disorder Medications Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Bipolar Disorder Medications Sales (K Units), 2019-2024
Table 15. By Type - Global Bipolar Disorder Medications Sales (K Units), 2025-2030
Table 16. By Application ? Global Bipolar Disorder Medications Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Bipolar Disorder Medications Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Bipolar Disorder Medications Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Bipolar Disorder Medications Sales (K Units), 2019-2024
Table 20. By Application - Global Bipolar Disorder Medications Sales (K Units), 2025-2030
Table 21. By Region ? Global Bipolar Disorder Medications Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Bipolar Disorder Medications Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Bipolar Disorder Medications Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Bipolar Disorder Medications Sales (K Units), 2019-2024
Table 25. By Region - Global Bipolar Disorder Medications Sales (K Units), 2025-2030
Table 26. By Country - North America Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Bipolar Disorder Medications Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Bipolar Disorder Medications Sales, (K Units), 2019-2024
Table 29. By Country - North America Bipolar Disorder Medications Sales, (K Units), 2025-2030
Table 30. By Country - Europe Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Bipolar Disorder Medications Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Bipolar Disorder Medications Sales, (K Units), 2019-2024
Table 33. By Country - Europe Bipolar Disorder Medications Sales, (K Units), 2025-2030
Table 34. By Region - Asia Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Bipolar Disorder Medications Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Bipolar Disorder Medications Sales, (K Units), 2019-2024
Table 37. By Region - Asia Bipolar Disorder Medications Sales, (K Units), 2025-2030
Table 38. By Country - South America Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Bipolar Disorder Medications Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Bipolar Disorder Medications Sales, (K Units), 2019-2024
Table 41. By Country - South America Bipolar Disorder Medications Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Bipolar Disorder Medications Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Bipolar Disorder Medications Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Bipolar Disorder Medications Sales, (K Units), 2025-2030
Table 46. AbbVie Inc. Company Summary
Table 47. AbbVie Inc. Bipolar Disorder Medications Product Offerings
Table 48. AbbVie Inc. Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. AbbVie Inc. Key News & Latest Developments
Table 50. Glaxo SmithKline (GSK) Company Summary
Table 51. Glaxo SmithKline (GSK) Bipolar Disorder Medications Product Offerings
Table 52. Glaxo SmithKline (GSK) Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Glaxo SmithKline (GSK) Key News & Latest Developments
Table 54. Eli Lily and Company Company Summary
Table 55. Eli Lily and Company Bipolar Disorder Medications Product Offerings
Table 56. Eli Lily and Company Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Eli Lily and Company Key News & Latest Developments
Table 58. Janssen Pharmaceuticals Company Summary
Table 59. Janssen Pharmaceuticals Bipolar Disorder Medications Product Offerings
Table 60. Janssen Pharmaceuticals Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Janssen Pharmaceuticals Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Bipolar Disorder Medications Product Offerings
Table 64. Johnson & Johnson Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. Astellas Pharma Inc Company Summary
Table 67. Astellas Pharma Inc Bipolar Disorder Medications Product Offerings
Table 68. Astellas Pharma Inc Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Astellas Pharma Inc Key News & Latest Developments
Table 70. Bristol Myers Squibb Company Summary
Table 71. Bristol Myers Squibb Bipolar Disorder Medications Product Offerings
Table 72. Bristol Myers Squibb Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Bristol Myers Squibb Key News & Latest Developments
Table 74. Gedeon Richter PLC. Company Summary
Table 75. Gedeon Richter PLC. Bipolar Disorder Medications Product Offerings
Table 76. Gedeon Richter PLC. Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Gedeon Richter PLC. Key News & Latest Developments
Table 78. H. Lundbeck A/S Company Summary
Table 79. H. Lundbeck A/S Bipolar Disorder Medications Product Offerings
Table 80. H. Lundbeck A/S Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. H. Lundbeck A/S Key News & Latest Developments
Table 82. Pfizer Inc. Company Summary
Table 83. Pfizer Inc. Bipolar Disorder Medications Product Offerings
Table 84. Pfizer Inc. Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Pfizer Inc. Key News & Latest Developments
Table 86. Novartis AG Company Summary
Table 87. Novartis AG Bipolar Disorder Medications Product Offerings
Table 88. Novartis AG Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Novartis AG Key News & Latest Developments
Table 90. Otsuka Holdings Co. Ltd Company Summary
Table 91. Otsuka Holdings Co. Ltd Bipolar Disorder Medications Product Offerings
Table 92. Otsuka Holdings Co. Ltd Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Otsuka Holdings Co. Ltd Key News & Latest Developments
Table 94. Validus Pharmaceuticals LLC. Company Summary
Table 95. Validus Pharmaceuticals LLC. Bipolar Disorder Medications Product Offerings
Table 96. Validus Pharmaceuticals LLC. Bipolar Disorder Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Validus Pharmaceuticals LLC. Key News & Latest Developments
Table 98. Bipolar Disorder Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 99. Global Bipolar Disorder Medications Capacity Market Share of Key Manufacturers, 2021-2024
Table 100. Global Bipolar Disorder Medications Production by Region, 2019-2024 (K Units)
Table 101. Global Bipolar Disorder Medications Production by Region, 2025-2030 (K Units)
Table 102. Bipolar Disorder Medications Market Opportunities & Trends in Global Market
Table 103. Bipolar Disorder Medications Market Drivers in Global Market
Table 104. Bipolar Disorder Medications Market Restraints in Global Market
Table 105. Bipolar Disorder Medications Raw Materials
Table 106. Bipolar Disorder Medications Raw Materials Suppliers in Global Market
Table 107. Typical Bipolar Disorder Medications Downstream
Table 108. Bipolar Disorder Medications Downstream Clients in Global Market
Table 109. Bipolar Disorder Medications Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Bipolar Disorder Medications Segment by Type in 2023
Figure 2. Bipolar Disorder Medications Segment by Application in 2023
Figure 3. Global Bipolar Disorder Medications Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Bipolar Disorder Medications Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Bipolar Disorder Medications Revenue, 2019-2030 (US$, Mn)
Figure 7. Bipolar Disorder Medications Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Bipolar Disorder Medications Revenue in 2023
Figure 9. By Type - Global Bipolar Disorder Medications Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Bipolar Disorder Medications Revenue Market Share, 2019-2030
Figure 11. By Type - Global Bipolar Disorder Medications Sales Market Share, 2019-2030
Figure 12. By Type - Global Bipolar Disorder Medications Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Bipolar Disorder Medications Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Bipolar Disorder Medications Revenue Market Share, 2019-2030
Figure 15. By Application - Global Bipolar Disorder Medications Sales Market Share, 2019-2030
Figure 16. By Application - Global Bipolar Disorder Medications Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Bipolar Disorder Medications Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Bipolar Disorder Medications Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Bipolar Disorder Medications Revenue Market Share, 2019-2030
Figure 20. By Region - Global Bipolar Disorder Medications Sales Market Share, 2019-2030
Figure 21. By Country - North America Bipolar Disorder Medications Revenue Market Share, 2019-2030
Figure 22. By Country - North America Bipolar Disorder Medications Sales Market Share, 2019-2030
Figure 23. US Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Bipolar Disorder Medications Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Bipolar Disorder Medications Sales Market Share, 2019-2030
Figure 28. Germany Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 29. France Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Bipolar Disorder Medications Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Bipolar Disorder Medications Sales Market Share, 2019-2030
Figure 37. China Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 41. India Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Bipolar Disorder Medications Revenue Market Share, 2019-2030
Figure 43. By Country - South America Bipolar Disorder Medications Sales Market Share, 2019-2030
Figure 44. Brazil Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Bipolar Disorder Medications Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Bipolar Disorder Medications Sales Market Share, 2019-2030
Figure 48. Turkey Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Bipolar Disorder Medications Revenue, (US$, Mn), 2019-2030
Figure 52. Global Bipolar Disorder Medications Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Bipolar Disorder Medications by Region, 2023 VS 2030
Figure 54. Bipolar Disorder Medications Industry Value Chain
Figure 55. Marketing Channels
